InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,503.41
(
-0.30%
)
US TECH 100
18,384.80
(
-0.21%
)
Dow Jones
40,755.75
(
-0.54%
)
Brent Oil
72.66
(
-0.16%
)
Bitcoin
56,748.12
(
1.05%
)
Post# of 704019
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Joe Stocks

Send PM Follow Ignore
Followers 217
Posts 28308
Boards Moderated 2
Alias Born 02/24/2002

Joe Stocks

Member Level

Re: Joe Stocks post# 40678

Friday, 11/01/2002 10:09:26 AM

Friday, November 01, 2002 10:09:26 AM

Post# of 704019
>>>In Wednesday's market monitor at OptionInvestor.com we mentioned
that there was some trader talk that Teva Pharmaceutical
(NASDAQ:TEVA) $77.43 might be added to the NASDAQ-100. This
proves true as the Israeli generic drug maker will join the
NASDAQ-100 Index (NDX.X) effective at the beginning of trading
November 7, replacing Concord EFS (NASDAQ:CEFT) $14.28, which is
moving its listing to the NYSE. Salomon Smith Barney expects
indexers to sell a total of 21.5 million CEFT shares and purchase
3.4 million TEVA shares.


Joe

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up